Recap of the third UNITE4TB webinar: Progress made to date in shortening TB treatment UNITE4TB held its third public webinar on Thursday 7 July, with a focus on the recent changes in the World Health Organization (WHO) guidelines for the treatment of Tuberculosis (TB) and an evaluation of the evidence underpinning the shortening of TB […]
The prosperity of the modern world is threatened by the emergence of drug resistant pathogens, pesticide-resistant insects and herbicide-resistant weeds. Novel investigational cancer drugs increase life expectancy, but fail when resistance develops. The same principles of evolution drive the development of resistance in all of these contexts, yet each field attacks the problem of resistance […]
On 26 July, James J. Collins and Richard Lee will be discussing the use of Synthetic biology and interdisciplinary approaches for antibiotic discovery.
In this webinar, the speakers will discuss will provide an overview of basic animal models and explain the basis for their selection and limitations for specific situations and needs to study the activity of antibiotics. The speakers will give the following presentations: - Overview of common animal models (Lynn Miesel) - Zebrafish larvae as an […]
On 23 August, Michael N. Dudley and Glenn Dale will discuss the Challenges and options in developing antibiotic combinations.
Since 2015, the World Antimicrobial Resistance Congress has attracted top thought leaders, hospitals, companies, and policymakers as the annual, go-to event in the Antimicrobial Resistance (AMR) space. We have grown into the most impactful event in advancing solutions to combat this pressing global health crisis. Diagnostic developers, antibiotic biotechs & pharmaceutical companies, stewardship technologies, access […]
The EMBO Workshop on Tuberculosis 2022, originally planned for September 2020 and postponed to 2022 due to the Covid-19 pandemic, has recently received again the support from EMBO, and is now scheduled to be held from September 12-16, 2022 at the Conference Centre (CIS) of the Institut Pasteur in Paris. The EMBO Workshop on Tuberculosis 2022 will be […]
About twenty people attended this webinar which focused on some highlights and challenges from three TB focused projects, namely UNITE4TB, ERA4TB, and TRIC-TB. The selected speakers, Modesto Remuinan-Blanco (TRIC-TB and GSK), Martin Boeree (UNITE4TB and Radboud UMC), Alfonso Mendoza-Losana (ERA4TB and Universidad Carlos III Madrid) and Oscar della Pasqua (ERA4TB and Consiglia Nazionale delle Ricerche) […]
Antimicrobial drug resistance (AMR) is an urgent global health problem. New antimicrobial drug development is increasingly viewed as a priority by national and international bodies. Co-sponsored by the American Society for Microbiology (ASM) and the European Society for Clinical Microbiology and Infectious Diseases (ESCMID), this multidisciplinary meeting will address the challenges, opportunities and current requirements […]
Please save the date for the 2022 Antimicrobial Resistance Conference organised by Infoma Connect. Conference theme: ACT NOW: INCENTIVES & STRATEGIES TO DRIVE INNOVATION IN THE ANTIMICROBIAL RESISTANCE MARKET. Topics: - Improve Government Funding. - Reform Reimbursement Schemes. - Promote Surveillance and Stewardship Programmes. - Discover and Develop Drugs and Novel Technology. See the full […]
